MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hon.70261

Медицинская библиотека · Hematological oncology · 2026

Divergent Clonal Trajectories of FLT3-ITD in Acute Myeloid Leukemia and Their Clinical and Transcriptomic Associations.

Tsai Xavier Cheng-Hong, Chang Yu-Sung, Tien Feng-Ming, Lo Min-Yen, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Yao Chi-Yuan, Yao Szu-Chi, Lin Chien-Chin, Ko Bor-Sheng, Yao Ming, Tien Hwei-Fang, Hou Hsin-An, Chou Wen-Chien

СтатьяПеревод в очереди

Аннотация

FLT3-ITD occurs in approximately 20%-25% of cases of adult AML and is associated with increased relapse risk and shorter survival. FLT3-ITD status informs AML risk at diagnosis, but its dynamic changes during disease evolution are not well defined. We hypothesized that divergent FLT3-ITD clonal trajectories are shaped by preexisting molecular features detectable at diagnosis. We analyzed 319 intensively treated adults who were newly diagnosed with non-M3 de novo AML who experienced relapse and had paired FLT3-ITD mutation data at diagnosis and relapse. Patients were classified into four clonal evolution patterns: maintained FLT3-ITD negative (FLT3-ITDnegative), FLT3-ITD loss (FLT3-ITDlost), FLT3-ITD acquisition (FLT3-ITDacquired), and maintained FLT3-ITD positive (FLT3-ITDpositive). The FLT3-ITDpositive group was strongly associated with concurrent NPM1 and/or DNMT3A mutations, which were enriched compared with those in other groups (p < 0.001). ELN 2022 risk categories differed across clonal evolution patterns, with favorable-risk disease declining progressively from the FLT3-ITDnegative to the FLT3-ITDpositive group (44.3%-6.1%) while intermediate-risk disease rose correspondingly (21.2%-73.5%; both p < 0.001). With a median follow-up of 96.8 months, patients in the FLT3-ITDacquired or FLT3-ITDpositive group had significantly inferior relapse-free and overall survival compared with those in the FLT3-ITDnegative group (p = 0.009 and p = 0.018, respectively, in univariate analyses; p = 0.001 and p = 0.006, respectively, in multivariate analyses adjusted for individual genetic risk features). Transcriptomics showed enrichment of inflammatory pathways in FLT3-ITDpositive cases that persisted after adjustment for NPM1/DNMT3A co-mutations and FLT3-ITD allelic ratio, together with an inferred monocyte-rich profile. Overall, FLT3-ITD evolution is associated with distinct genomic and transcriptomic features present at diagnosis. TRIAL REGISTRATION: 202203013RSD.

Для цитирования: Tsai Xavier Cheng-Hong, Chang Yu-Sung, Tien Feng-Ming, Lo Min-Yen, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Yao Chi-Yuan, Yao Szu-Chi, Lin Chien-Chin, Ko Bor-Sheng, Yao Ming, Tien Hwei-Fang, Hou Hsin-An, Chou Wen-Chien. Divergent Clonal Trajectories of FLT3-ITD in Acute Myeloid Leukemia and Their Clinical and Transcriptomic Associations.. Hematological oncology. 2026. DOI: 10.1002/hon.70261.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.